Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 28 (RPS10P28) is a processed pseudogene related to the functional ribosomal protein S10 (RPS10) gene found in humans[1][4][6]. Pseudogenes are genetic elements that resemble protein-coding genes but have lost their coding or regulatory potential due to mutations and are typically nonfunctional. RPS10P28 does not code for a functional protein and is not considered a biological or therapeutic target[1][4][6][9]. There is no evidence for participation in disease, biological processes, or drug interactions. The functional RPS10 protein is a component of the 40S subunit of cytoplasmic ribosomes, essential for protein synthesis, but RPS10P28 itself has no active molecular function. Key clarifications and context: Is this a therapeutic target? No; RPS10P28 is a pseudogene, not a protein, receptor, enzyme, or other actionable target in drug discovery or clinical settings[1][4][9]. Is there something wrong with this target? Yes; identifying RPS10P28 as a molecular target is incorrect, as it does not have a functional product or role amenable to therapeutic intervention[1][9]. Distinction from RPS10: The functional protein-coding gene is RPS10 (ribosomal protein S10), which does have a biological role in the ribosome and has clinical relevance in disorders such as Diamond-Blackfan anemia[5][7]. RPS10P28 is just one of many dispersed processed pseudogenes of RPS10 in the human genome[1][6][9]. Summary: "Ribosomal protein S10 pseudogene 28" (RPS10P28) is a non-functional, processed pseudogene without known biological activity or disease association, and is not a valid therapeutic or diagnostic target[1][4][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 28 (RPS10P28).